Regulatory Role of MicroRNAs in Aging-related Abdominal Aortic Aneurysm Disease

MicroRNA 在衰老相关腹主动脉瘤疾病中的调节作用

• 批准号: 9339571
• 负责人: Philip S Tsao
• 金额: --
• 依托单位: VETERANS ADMIN PALO ALTO HEALTH CARE SYS
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-04-01 至 2019-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9339571
• 关键词: 3' Untranslated Regions; Abdominal Aortic Aneurysm; Acceleration; Age; Age-Years; Aging; Aneurysm; Angiotensin II; Animal Model; Apoptosis; Binding; Biochemical; Biological Assay; Biology; Blood Vessels; CHI3L1 gene; Cell Adhesion; Cell Culture Techniques; Cell model; Cell physiology; Cells; Cessation of life; Chemotaxis; Chronic; Complex; Data; Development; Disease; Disease Progression; Down-Regulation; Elderly; Endothelial Cells; Event; Family suidae; Gene Expression; Gene Targeting; Genes; Genetic; Genetic Transcription; Growth; Health; Histologic; Human; In Vitro; Infiltration; Inflammation; Inflammatory; Interleukin-6; Intervention; Lead; Mediating; Methods; MicroRNAs; Modeling; Molecular; Molecular Models; Monitor; Mus; Mutagenesis; Mutate; Operative Surgical Procedures; Oxidative Stress; Pancreatic Elastase; Pathway interactions; Pharmacology; Play; Premature aging syndrome; Prevalence; Procedures; Process; Regulation; Research; Risk Factors; Role; Rupture; Ruptured Abdominal Aortic Aneurysm; Second Messenger Systems; Signal Pathway; Signal Transduction; Small Interfering RNA; Smooth Muscle Myocytes; Specificity; Stents; Structure; Therapeutic; Time; Tissues; Tobacco use; Transfection; Ultrasonography; Up-Regulation; Vascular Smooth Muscle; Veterans; age related; aged; animal tissue; base; cell type; clinical translation; cytokine; in vivo; inflammatory marker; macrophage; male; molecular modeling; monocyte; mouse model; novel; novel therapeutic intervention; older patient; overexpression; permissiveness; physiologic model; pre-clinical; prevent; protein expression; public health relevance; sex; success; therapeutic target; vascular inflammation

DESCRIPTION (provided by applicant): Abdominal aortic aneurysm (AAA) disease is a common, morbid and highly lethal disease of primarily older patients. While surgery and stent-grafting are highly effective in preventing death by rupture from larger AAA, they represent complex procedures with multiple potential complica-tions. Importantly, there are currently no therapeutic strategies that limit the growth of aneurysms, due in large part to a lack of understanding of the underlying molecular mechanisms of disease and progression. In addition to tobacco use, genetic predilection, and male sex, the most important risk factor for AAA is advanced age. As such, it is not surprising that over 68,000 Veterans within the VHA suffer from AAA. After age 65 years, the prevalence of AAA increases by 6% per decade. To better understand this relationship, we examined a preclinical animal model of AAA in both young and aged male mice, and observed accelerated disease formation and enhanced interleukin-6(IL6)- based inflammatory signaling with aging. We also found that miR-24 is downregulated in murine AAA models, as well as human AAA tissue. Furthermore, microarray transcriptional profiling showed that a highly significant percentage of the putative targets of miR-24 were differentially and inversely upregulated during AAA development. Additionally we found that miR-24 is downregulated by IL6 in vascular smooth muscle and macrophages in vitro. We hypothesize aging enhances IL6 signaling, leading to downregulation of vascular miR-24. Reduced activity of miR-24, in turn, is permissive for a panel of downstream inflammatory genes that play a role in aging-accelerated AAA development. Therefore, enhancing miR-24 expression and activity within the aortic wall may have therapeutic benefit. To investigate this molecular cascade, we will use pharmacological and molecular methods to delineate the signaling events initiated by IL6 in vitro that result in decreased miR-24 levels (Specific Aim 1). Next, we will elucidate the effects manipulating miR-24 levels have upon inflammatory gene expression and cellular function (Specific Aim 2). Finally, we will alter miR-24 levels in vivo to evaluate the effects upon age-accelerated AAA formation (Specific Aim 3). Completion of these specific aims will delineate a novel mechanism that may underlie age-related vascular inflammation and accelerated aneurysm formation and provide the basis for clinical translation.

描述（由申请人提供）：